logo
  

Bank Of America Rejects Calls By AIG To Renegotiate $8.5 Bln Settlement Of 2011

Financial services major Bank of America Corp. (BAC) is said to have rejected a request from insurer American International Group, Inc. (AIG) and other investors to renegotiate the $8.5 billion settlement deal that was struck in July 2011 over soured mortgage-backed securities. This was reportedly revealed by AIG in a court filing.

The request from AIG came after the New York State Judge Barbara Kapnick suggested that the parties reach a settlement through mediation on the long-running dispute over the fairness of the 2011 settlement. The losses suffered on debt securities by investor's were originally valued at $105 billion.

Bank of America has reportedly declined to further negotiations on the settlement as the deal was struck after hard and extended negotiations. The settlement is still subject to the approval by the Judge. However, Bank of America is reportedly confident that it will be approved even without renegotiations.

A small group of investors, including AIG, are pushing for the renegotiations on the settlement, while a group of another 22 investors, including the Federal Reserve Bank of New York, BlackRock, Inc. (BLK) and MetLife, Inc. (MET), deem the settlement as fair and want it to be approved by the judge at the earliest.

The judge can only approve or reject the settlement deal, but does not have the power to increase or decrease the settlement amount.

The mortgage-backed securities were originally issued Countrywide Financial Corp., which was acquired by Bank of America in 2008. The bank has already said to have spent $45 billion on legal expenses linked to the acquisition.

AIG closed Thursday's regular trading session at $44.48, up $0.86 or 1.97% on a volume of 16.69 million shares, and BAC closed at $13.01, up $0.25 or 1.96% on a volume of 124.62 million shares.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT